Global Urolithin B Market Strategic Research Report

Scope of the Report

The global Urolithin B market size is predicted to grow from US$ 27.01 million in 2025 to US$ 40.9 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

In 2024, global Urolithin B production reached approximately 63 tons, with an average global market price of around US$ 416,000 per ton. In 2024, the global's total production capacity of Urolithin B reached 95 tons.The industry average gross profit margin of this product reached 32%.

Urolithin B is a natural metabolite produced by gut microbiota, derived from ellagitannins found in foods such as pomegranates and walnuts. Due to its potential in antioxidation, anti-inflammation, and metabolic regulation, it is attracting attention from the research community and the market. The upstream core is the raw material production and technological research and development of urolithin B. Companies mainly extract ellagitannins from natural plants (such as pomegranate peel and nut shells) or produce urolithin B monomers on a large scale through chemical synthesis and microbial fermentation. This segment has high technological barriers and is concentrated in a few raw material companies with biotransformation or synthesis capabilities. The output is high-purity raw material powder, and its price is directly related to purity (usually 90%-99%), production capacity, and technological costs, forming the basic supply end of the industry chain. Midstream companies transform upstream raw materials into end products, addressing the problems of poor water solubility and low bioavailability of urolithin B (often using cyclodextrin inclusion complexation and nanoemulsification technologies). Manufacturers of health products, cosmetics, and functional foods then combine the raw materials with other ingredients to produce specific products such as capsules, tablets, and skincare products. Downstream currently focuses on dietary supplements (anti-aging, mitochondrial health) and high-end skincare products (antioxidant, anti-inflammatory), while its presence in the pharmaceutical field is still in the clinical research stage.

In recent years, research on the mechanism by which urolithin B can efficiently cross the blood-brain barrier to exert its neuroprotective effects has provided crucial scientific support for its application in high-value areas such as anti-aging and prevention of neurodegenerative diseases (e.g., Alzheimer's disease). This upgrade in understanding from "traditional antioxidant" to "precise cellular metabolic regulation" is its core competitive advantage, distinguishing it from ordinary health supplements.

The global aging population and the shift in health concepts among consumers (especially high-net-worth individuals) from "disease treatment" to "proactive prevention and function enhancement" perfectly align with the huge market demand for "healthy aging" given urolithin B's potential in promoting mitochondrial health and reducing chronic inflammation (one of the main culprits of aging).

Currently, its applications are rapidly expanding from dietary supplements to high-end functional skincare products (focusing on anti-aging and repair) and specific medical nutritional products. The gradually clarifying regulatory environment (e.g., some countries managing it as a new food ingredient) has also created conditions for the compliant market launch of its products.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Urolithin B market?

What factors are driving Urolithin B market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Urolithin B market opportunities vary by end market size?

How does Urolithin B break out by Type, by Application?

This report presents a comprehensive overview of the global Urolithin B market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity: >98%
• Purity: >99%
• Others

Segment by Production Source

• Natural Extraction
• Chemical Synthesis

Segment by Product Specification

• Industrial Grade
• Food Grade

Segment by Existence Form

• Powder
• Solution

Segment by Application

• Food Additives
• Cosmetics
• Drugs and Supplements
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Urolithin B market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Food Additives, Cosmetics, Drugs and Supplements evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact